European Archives - Page 51 of 1108 - European Medical Journal

Dupilumab Reduces Airway Inflammation in Type 2 Asthma

A Phase IV trial has demonstrated that dupilumab significantly reduces airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma.

Cancer Screening Rates Rebound Post-Pandemic, But Disparities Remain

Explore the rates of screening for breast and colorectal cancer post-pandemic.

Researchers Have Identified Gut Microbiome Ratios Linked to Multiple Sclerosis

Gut microbiome study identifies microbial ratio linked to multiple sclerosis severity, offering potential for diagnostics and therapies.

Beyond Symptom Control: Can We Achieve Deep Remission in Psoriasis?

In this episode, Jonathan Sackier welcomes Andrew Blauvelt, a distinguished dermatologist and leading expert in immunodermatology. They discuss groundbreaking advancements in psoriasis treatment, including the role of high-dose biologics in achieving deep remission and how IL-23 inhibition is transforming long-term disease management.

Woman's hand holding pill

Daily pill for endometriosis to be offered by NHS

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.

Study Highlights Long-Term Safety of T Cell Gene Therapy

A study of 783 patients in 38 T cell therapy trials reveals reassuring results about the long-term safety of gene therapies for HIV-1 and cancer, with only 2.3% developing secondary malignancies.

Study Links Poor Sleep Patterns to Blood Sugar Fluctuations

Inadequate sleep duration and persistent late sleep onset are associated with significant fluctuations in blood glucose levels according to a recent study.

Advances in Allergic Asthma Treatment: A Comparative Study

Given that 60% of asthma-related costs are attributed to severe, uncontrolled cases, the need for cost-effective treatment alternatives is crucial.

EMJ's Spring journal is here

In this edition, spotlighting the microbiome and cutting-edge healthcare advances, explore insights on gut microbes, oesophageal cancer…

The Future of Microbiome-Based Therapeutics

The 32nd United European Gastroenterology Week, held from 12th–15th October 2024 in Vienna, Austria, brought together over 11,500…